Related Experiment Video
Updated: May 22, 2026
05:44
Formation of Dispersible Taohong Siwu Tablets
Published on: February 3, 2023
On lehas (linctus formulations).
139, Gurudham Colony, Varanasi - 221001, India.
Ancient Science of Life
|May 5, 2012
Summary
This study provides an English translation of the Lehdhyaya section from the Kasyapa-samhita, Sutrasthana (chapters 1-6). This work makes ancient Ayurvedic principles accessible to a wider audience.
Area of Science:
- Ayurvedic medicine
- Classical Indian medical texts
- Sanskrit literature translation
Background:
- The Kasyapa-samhita is a foundational text in Ayurvedic pediatrics.
- Understanding its core principles requires accurate translations.
- Lehdhyaya, Sutrasthana 1-6, contains essential foundational knowledge.
Purpose of the Study:
- To provide a scholarly English translation of Lehdhyaya, Sutrasthana 1-6 of the Kasyapa-samhita.
- To enhance accessibility of classical Ayurvedic pediatric knowledge.
- To facilitate further research and clinical application of these ancient teachings.
Main Methods:
- Critical analysis of the original Sanskrit text.
- Comparative study with existing commentaries.
- Linguistic and contextual interpretation for accurate English rendering.
Main Results:
- A comprehensive English translation of Lehdhyaya, Sutrasthana 1-6 is presented.
- Key concepts and terminology are clarified.
- The translation aims for fidelity to the original meaning and intent.
Conclusions:
- This translation serves as a valuable resource for students, researchers, and practitioners of Ayurveda.
- It bridges the gap between classical Sanskrit texts and modern understanding.
- Promotes wider dissemination and application of Kasyapa-samhita's pediatric insights.
More Related Videos
Related Concept Videos
01:11Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
01:27Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...